Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Session Type:

Availability:

  • Sort by:
  • Browse by:
<< first | < prev page: of 14 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 11 12 13 14 presentations: 1 to 50 of 675
THEMED DISCUSSION: KSHV VIROLOGY AND PATHOGENESIS
THEMED DISCUSSION LEADER
Blossom Damania
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
from CROI 2019 on March 5, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: KSHV VIROLOGY AND PATHOGENESIS
PRIMARY ROLE OF KSHV IN PATHOGENESIS OF ENDEMIC AND EPIDEMIC KAPOSI SARCOMA   (ABSTRACT 270)
Salum Juma Lidenge
University of Nebraska-Lincoln, Lincoln, NE, USA
from CROI 2019 on March 5, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: KSHV VIROLOGY AND PATHOGENESIS
METABOLIC ABNORMALITIES IN CD8 T CELLS FROM HIV+ INDIVIDUALS WITH KAPOSI SARCOMA   (ABSTRACT 271)
Genevieve Tyndale Clutton
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
from CROI 2019 on March 5, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: KSHV VIROLOGY AND PATHOGENESIS
SINGLE CELL EVALUATION OF KAPOSI SARCOMA TUMORS REVEALS COMPLEX IMMUNE INFILTRATE   (ABSTRACT 272)
Warren Phipps
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
from CROI 2019 on March 5, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: KSHV VIROLOGY AND PATHOGENESIS
NEW VARIANT OF KAPOSI SARCOMA–ASSOCIATED HERPESVIRUS IN MEN WHO HAVE SEX WITH MEN   (ABSTRACT 273)
Aude Jary
AP–HP, Hôpitaux Universitaires Pitié Salpêtrière, Paris, France
from CROI 2019 on March 5, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: KSHV VIROLOGY AND PATHOGENESIS
QUESTIONS AND ANSWERS
from CROI 2019 on March 5, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: LETS CHECK IN! NEW TOOLS FOR MONITORING ART AND PrEP ADHERENCE
THEMED DISCUSSION LEADER
Rodolphe Garraffo
Université de Nice-Sophia-Antipolis, Hôpital Pasteur, CHU de Nice, Nice, France
from CROI 2019 on March 5, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: LETS CHECK IN! NEW TOOLS FOR MONITORING ART AND PrEP ADHERENCE
PI DRUG-LEVEL TESTING AS A SCREENING TOOL FOR DRUG RESISTANCE IN 2ND-LINE ART FAILURE   (ABSTRACT 461)
Lucas Etienne Hermans
University Medical Center Utrecht, Johannesburg, South Africa
from CROI 2019 on March 5, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: LETS CHECK IN! NEW TOOLS FOR MONITORING ART AND PrEP ADHERENCE
PLASMA EFV AND TFV VS DRIED BLOOD SPOT TFV-DP TO PREDICT VIRAL SUPPRESSION IN WOMEN   (ABSTRACT 462)
Tamsin Kate Phillips
University of Cape Town, Cape Town, South Africa
from CROI 2019 on March 5, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: LETS CHECK IN! NEW TOOLS FOR MONITORING ART AND PrEP ADHERENCE
TENOFOVIR DIPHOSPHATE IN DRIED BLOOD SPOTS FOLLOWING ESCALATING TAF/FTC DOSING   (ABSTRACT 463)
Jenna Yager
University of Colorado, Aurora, CO, USA
from CROI 2019 on March 5, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: LETS CHECK IN! NEW TOOLS FOR MONITORING ART AND PrEP ADHERENCE
VALIDATION OF A URINE TFV IMMUNOASSAY FOR REAL-TIME PREP AND ART ADHERENCE TESTING   (ABSTRACT 464)
Monica Gandhi
University of California San Francisco, San Francisco, CA, USA
from CROI 2019 on March 5, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: LETS CHECK IN! NEW TOOLS FOR MONITORING ART AND PrEP ADHERENCE
URINE FTC AND TFV CONCENTRATIONS AS POTENTIAL BIOMARKERS FOR ARV ADHERENCE   (ABSTRACT 465)
Richard Haaland
Centers for Disease Control and Prevention, Laboratory Branch, Division of HIV/AIDS Prevention, Atlanta, GA, USA
from CROI 2019 on March 5, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: LETS CHECK IN! NEW TOOLS FOR MONITORING ART AND PrEP ADHERENCE
QUESTIONS AND ANSWERS
from CROI 2019 on March 5, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: STRUCTURE AND LOCATION OF PROVIRUSES ON ART
THEMED DISCUSSION LEADER
Sarah Palmer
The Westmead Institute for Medical Research, Westmead, NSW, Australia
from CROI 2019 on March 5, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: STRUCTURE AND LOCATION OF PROVIRUSES ON ART
A METHOD TO DETERMINE BOTH THE INTEGRATION SITES AND SEQUENCES OF HIV-1 PROVIRUSES   (ABSTRACT 338)
Sean Patro
National Cancer Institute, Frederick, MD, USA
from CROI 2019 on March 5, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: STRUCTURE AND LOCATION OF PROVIRUSES ON ART
DISTINCT CHROMOSOMAL POSITIONS OF INTACT HIV-1 PROVIRUSES   (ABSTRACT 339)
Kevin Einkauf
Brigham and Women's Hospital, Cambridge, MA, USA
from CROI 2019 on March 5, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: STRUCTURE AND LOCATION OF PROVIRUSES ON ART
RELATIONSHIP BETWEEN INTACT HIV-1 PROVIRUSES AND PLASMA REBOUND VIRUSES   (ABSTRACT 340)
Ching-Lan Lu
The Rockefeller University, New York, NY, USA
from CROI 2019 on March 5, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: STRUCTURE AND LOCATION OF PROVIRUSES ON ART
LANDSCAPE OF HIV-1 INTEGRATION SITES IN LYMPHOID TISSUE FROM ART-TREATED INDIVIDUALS   (ABSTRACT 341)
Vincent H. Wu
University of Pennsylvania, Philadelphia, PA, USA
from CROI 2019 on March 5, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: STRUCTURE AND LOCATION OF PROVIRUSES ON ART
GENETIC AND AGE DISTRIBUTION OF LATENT HIV SEQUENCES IN CD4+ T-CELL SUBSETS   (ABSTRACT 342)
Zabrina Brumme
Simon Fraser University, Burnaby, British Columbia, Canada
from CROI 2019 on March 5, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: STRUCTURE AND LOCATION OF PROVIRUSES ON ART
QUESTIONS AND ANSWERS
from CROI 2019 on March 5, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: THE MASKED MARVELS YOU DON'T WANT TO MEET: SYPHILIS AND LGV
THEMED DISCUSSION LEADER
Khalil G Ghanem
Johns Hopkins University, Baltimore, MD, USA
from CROI 2019 on March 5, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: THE MASKED MARVELS YOU DON'T WANT TO MEET: SYPHILIS AND LGV
EFFECTIVE TREATMENT OF LYMPHOGRANULOMA PROCTITIS WITH EXTENDED AZITHROMYCIN REGIMEN   (ABSTRACT 1011)
José L Blanco
Hospital Clinic, Barcelona, Spain
from CROI 2019 on March 5, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: THE MASKED MARVELS YOU DON'T WANT TO MEET: SYPHILIS AND LGV
ADHERENCE OF HEALTH CARE PROVIDERS TO CDC LUMBAR-PUNCTURE CRITERIA AMONG SYPHILIS/HIV   (ABSTRACT 1012)
Barbara Labella Henriques
Universidad de São Paulo, São Paulo, Brazil
from CROI 2019 on March 5, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: THE MASKED MARVELS YOU DON'T WANT TO MEET: SYPHILIS AND LGV
HEARING LOSS IN UNSELECTED INDIVIDUALS WITH SYPHILIS   (ABSTRACT 1013)
Meena Ramchandani
University of Washington, Seattle, WA, USA
from CROI 2019 on March 5, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: THE MASKED MARVELS YOU DON'T WANT TO MEET: SYPHILIS AND LGV
COGNITIVE IMPAIRMENT IN INDIVIDUALS WITH SYPHILIS   (ABSTRACT 1014)
Kevin Robertson
University of North Carolina - Chapel Hill, Chapel Hill, NC, USA
from CROI 2019 on March 5, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: THE MASKED MARVELS YOU DON'T WANT TO MEET: SYPHILIS AND LGV
RESPONSE TO SYPHILIS TREATMENT: CDC GUIDELINES IN HIV-INFECTED ADULTS ON CART   (ABSTRACT 1015)
Melody Ren
University of Toronto, Toronto, Ontario, Canada
from CROI 2019 on March 5, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: THE MASKED MARVELS YOU DON'T WANT TO MEET: SYPHILIS AND LGV
QUESTIONS AND ANSWERS
from CROI 2019 on March 5, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: WOMEN WITH HIV: ARE OUTCOMES DIFFERENT?
THEMED DISCUSSION LEADER
Judith Aberg
Icahn School of Medicine at Mount Sinai, New York, NY, USA
from CROI 2019 on March 5, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: WOMEN WITH HIV: ARE OUTCOMES DIFFERENT?
IMPORTANT SEX DIFFERENCES IN OUTCOMES FOR INDIVIDUALS PRESENTING FOR THIRD-LINE ART   (ABSTRACT 518)
Catherine Godfrey
National Institute of Health, Bethesda, MD, USA
from CROI 2019 on March 5, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: WOMEN WITH HIV: ARE OUTCOMES DIFFERENT?
DEPRESSION IS A STRONGER PREDICTOR OF EXECUTIVE DYSFUNCTION IN HIV+ WOMEN THAN MEN   (ABSTRACT 516)
Leah H Rubin
Johns Hopkins University, Baltimore, MD, USA
from CROI 2019 on March 5, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: WOMEN WITH HIV: ARE OUTCOMES DIFFERENT?
GENDER AND COINFECTIONS CONTRIBUTE TO IMMUNE ACTIVATION IN TREATED HIV INFECTION   (ABSTRACT 517)
Hendrik Streeck
Institute for HIV Research, Essen, Germany
from CROI 2019 on March 5, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: WOMEN WITH HIV: ARE OUTCOMES DIFFERENT?
TENOFOVIR ALAFENAMIDE VS TENOFOVIR DF IN WOMEN: POOLED ANALYSIS OF 7 CLINICAL TRIALS   (ABSTRACT 519)
Melanie Thompson
AIDS Research Consortium of Atlanta, Atlanta, GA, USA
from CROI 2019 on March 5, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: WOMEN WITH HIV: ARE OUTCOMES DIFFERENT?
EFFECT OF ANTIRETROVIRAL THERAPY AND IMMUNE RECONSTITUTION ON VAGINAL MICROBIOME   (ABSTRACT 520)
Zoe Packman
Johns Hopkins University, Baltimore, MD, USA
from CROI 2019 on March 5, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: WOMEN WITH HIV: ARE OUTCOMES DIFFERENT?
QUESTIONS AND ANSWERS
from CROI 2019 on March 5, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: EARLY EVENTS
THEMED DISCUSSION LEADER
Michael Emerman
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
from CROI 2019 on March 6, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: EARLY EVENTS
ENTRY KINETICS OF GLOBALLY REPRESENTATIVE AND VERTICALLY TRANSMITTED HIV ENVELOPES   (ABSTRACT 166)
Nicholas E. Webb
University of California Los Angeles, Los Angeles, CA, USA
from CROI 2019 on March 6, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: EARLY EVENTS
CD4-DEPENDENT MODULATION OF HIV-1 ENTRY BY LY6E   (ABSTRACT 167)
Shan-Lu Liu
The Ohio State University, Columbus, OH, USA
from CROI 2019 on March 6, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: EARLY EVENTS
ELUCIDATING MECHANISMS BY WHICH MUTATIONS IN ENV CONTRIBUTE TO HIV-1 DRUG RESISTANCE   (ABSTRACT 168)
Rachel Van Duyne
National Cancer Institute, Frederick, MD, USA
from CROI 2019 on March 6, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: EARLY EVENTS
NONRANDOM GENERATION OF DELETIONS WITHIN HIV PROVIRAL SEQUENCES IN VIVO   (ABSTRACT 169)
Bonnie Hiener
The Westmead Institute for Medical Research, Westmead, Australia
from CROI 2019 on March 6, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: EARLY EVENTS
HOST FACTORS INFLUENCE SIV AND HIV-1 INFECTION AND SENSITIVITY TO CAPSID INHIBITORS   (ABSTRACT 170)
Carsten Münk
Heinrich-Heine-University Hospital, Düsseldorf, Germany
from CROI 2019 on March 6, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: EARLY EVENTS
QUESTIONS AND ANSWERS
from CROI 2019 on March 6, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: INSIGHT FROM ANALYTICAL TREATMENT INTERRUPTIONS
THEMED DISCUSSION LEADER
John Frater
University of Oxford, Oxford, United Kingdom
from CROI 2019 on March 6, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: INSIGHT FROM ANALYTICAL TREATMENT INTERRUPTIONS
ANALYTICAL TREATMENT INTERRUPTION (ATI) IN PATIENTS WITH VERY SMALL HIV RESERVOIR   (ABSTRACT 389)
Eric Florence
Institute of Tropical Medicine, Antwerpen, Antwerpen, Belgium
from CROI 2019 on March 6, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: INSIGHT FROM ANALYTICAL TREATMENT INTERRUPTIONS
N-803 INDUCES ROBUST SIV REACTIVATION IN ART-TREATED CD8-DEPLETED MACAQUES   (ABSTRACT 390)
Julia Bergild McBrien
Yerkes National Primate Research Center, Atlanta, GA, USA
from CROI 2019 on March 6, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: INSIGHT FROM ANALYTICAL TREATMENT INTERRUPTIONS
REBOUND OF HIV-1 IN CEREBROSPINAL FLUID AFTER TREATMENT INTERRUPTION   (ABSTRACT 391)
Richard W Price
University of California San Francisco, San Fransisco, CA, USA
from CROI 2019 on March 6, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: INSIGHT FROM ANALYTICAL TREATMENT INTERRUPTIONS
COMPARTMENTALIZED HIV REBOUND IN THE MALE GENITAL TRACT AFTER ART INTERRUPTION   (ABSTRACT 392)
Sara Gianella
University of California San Diego, La Jolla, CA, USA
from CROI 2019 on March 6, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: INSIGHT FROM ANALYTICAL TREATMENT INTERRUPTIONS
SEEKING SUPPRESSION IN HAVARTI: VIREMIA & T CELLS AFTER VEDOLIZUMAB & ATI IN HIV/ART   (ABSTRACT 393)
Michaeline McGuinty
University of Ottawa, Ottawa, Canada
from CROI 2019 on March 6, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: INSIGHT FROM ANALYTICAL TREATMENT INTERRUPTIONS
QUESTIONS AND ANSWERS
from CROI 2019 on March 6, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: NOVEL PUBLIC HEALTH: CLUSTERS, CONTRASTS AND PHYLOGENETICS
THEMED DISCUSSION LEADER
Frank Tanser
Africa Health Research Institute, Durban, South Africa
from CROI 2019 on March 6, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: NOVEL PUBLIC HEALTH: CLUSTERS, CONTRASTS AND PHYLOGENETICS
INCIDENT INFECTION IN HIGH-PRIORITY HIV MOLECULAR TRANSMISSION CLUSTERS   (ABSTRACT 856)
Joel O. Wertheim
University of California, San Diego, San Diego, CA, USA
from CROI 2019 on March 6, 2019 1:30 PM-2:30 PM
<< first | < prev page: of 14 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 11 12 13 14 presentations: 1 to 50 of 675